JPH09510983A - 好酸球の顆粒球の病理学的な過剰反応性を減少するためのキサンチン誘導体の使用、新規なキサンチン化合物およびそれらの製法 - Google Patents
好酸球の顆粒球の病理学的な過剰反応性を減少するためのキサンチン誘導体の使用、新規なキサンチン化合物およびそれらの製法Info
- Publication number
- JPH09510983A JPH09510983A JP7525385A JP52538595A JPH09510983A JP H09510983 A JPH09510983 A JP H09510983A JP 7525385 A JP7525385 A JP 7525385A JP 52538595 A JP52538595 A JP 52538595A JP H09510983 A JPH09510983 A JP H09510983A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- methyl
- group
- xanthine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4411660.8 | 1994-04-05 | ||
DE4411660A DE4411660A1 (de) | 1994-04-05 | 1994-04-05 | Verwendung von Xanthinderivaten zur Reduktion der pathologischen Hyperreagibilität eosinophiler Granulozyten, neue Xanthinverbindungen und Verfahren zu deren Herstellung |
PCT/EP1995/001060 WO1995026727A1 (de) | 1994-04-05 | 1995-03-21 | Verwendung von xanthinderivaten zur reduktion der pathologischen hyperreagibilität eosinophiler granulozyten, neue xanthinverbindungen und verfahren zu deren herstellung |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH09510983A true JPH09510983A (ja) | 1997-11-04 |
Family
ID=6514636
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP7525385A Abandoned JPH09510983A (ja) | 1994-04-05 | 1995-03-21 | 好酸球の顆粒球の病理学的な過剰反応性を減少するためのキサンチン誘導体の使用、新規なキサンチン化合物およびそれらの製法 |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0758239A1 (de) |
JP (1) | JPH09510983A (de) |
KR (1) | KR100373948B1 (de) |
CN (1) | CN1098686C (de) |
AU (1) | AU695488B2 (de) |
CA (1) | CA2187081A1 (de) |
DE (1) | DE4411660A1 (de) |
HU (1) | HUT74732A (de) |
RU (1) | RU2159617C2 (de) |
UA (1) | UA39136C2 (de) |
WO (1) | WO1995026727A1 (de) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005529934A (ja) * | 2002-05-31 | 2005-10-06 | シェーリング コーポレイション | キサンチンホスホジエステラーゼvインヒビターおよびその前駆物質を調製するプロセス |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6294350B1 (en) | 1997-06-05 | 2001-09-25 | Dalhousie University | Methods for treating fibroproliferative diseases |
US5985592A (en) * | 1997-06-05 | 1999-11-16 | Dalhousie University | Uses for pentoxifylline or functional derivatives/metabolites thereof |
AU3370099A (en) * | 1998-03-31 | 1999-10-18 | Mayo Foundation For Medical Education And Research | Use of platelet activating factor (paf) inhibitors to inhibit il-5 induced eosinophil activation or degranulation |
SI1509525T1 (sl) * | 2002-05-31 | 2006-12-31 | Schering Corp | Postopek priprave inhibitorjev ksantinske fosfodiesteraze V in njihovih prekurzorjev |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8918297D0 (en) * | 1989-08-10 | 1989-09-20 | Beecham Group Plc | Novel treatment |
DD298051A5 (de) * | 1989-08-16 | 1992-02-06 | ��@���������@�������k�� | Verfahren zur herstellung eines therapeutischen agens zur behandlung von verdauungskrankheiten |
GB9023783D0 (en) * | 1990-11-01 | 1990-12-12 | Celltech Ltd | Pharmaceutical product |
IL100195A0 (en) * | 1990-11-30 | 1992-08-18 | Hoechst Roussel Pharma | Use of xanthines for the preparation of a medicament having immuno suppressing activity |
WO1993003728A1 (en) * | 1991-08-27 | 1993-03-04 | Temple University Of The Commonwealth System Of | Xanthine suppression of antigen activation of t- or b-cells |
IL99368A (en) * | 1991-09-02 | 1996-01-19 | Teva Pharma | Preparations for the treatment of psoriasis and atopic dermatitis, which contain the result of xanthine |
US5473070A (en) * | 1992-11-16 | 1995-12-05 | Cell Therapeutics, Inc. | Substituted long chain alcohol xanthine compounds |
-
1994
- 1994-04-05 DE DE4411660A patent/DE4411660A1/de not_active Withdrawn
-
1995
- 1995-03-21 CN CN95192342A patent/CN1098686C/zh not_active Expired - Fee Related
- 1995-03-21 JP JP7525385A patent/JPH09510983A/ja not_active Abandoned
- 1995-03-21 UA UA96114334A patent/UA39136C2/uk unknown
- 1995-03-21 WO PCT/EP1995/001060 patent/WO1995026727A1/de not_active Application Discontinuation
- 1995-03-21 CA CA002187081A patent/CA2187081A1/en not_active Abandoned
- 1995-03-21 EP EP95912260A patent/EP0758239A1/de not_active Withdrawn
- 1995-03-21 AU AU19510/95A patent/AU695488B2/en not_active Ceased
- 1995-03-21 RU RU96121791/14A patent/RU2159617C2/ru active
- 1995-03-21 HU HU9602712A patent/HUT74732A/hu unknown
- 1995-03-21 KR KR1019960705541A patent/KR100373948B1/ko not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005529934A (ja) * | 2002-05-31 | 2005-10-06 | シェーリング コーポレイション | キサンチンホスホジエステラーゼvインヒビターおよびその前駆物質を調製するプロセス |
Also Published As
Publication number | Publication date |
---|---|
EP0758239A1 (de) | 1997-02-19 |
UA39136C2 (uk) | 2001-06-15 |
RU2159617C2 (ru) | 2000-11-27 |
KR970702044A (ko) | 1997-05-13 |
AU1951095A (en) | 1995-10-23 |
WO1995026727A1 (de) | 1995-10-12 |
KR100373948B1 (ko) | 2003-06-09 |
DE4411660A1 (de) | 1995-10-12 |
HU9602712D0 (en) | 1996-11-28 |
AU695488B2 (en) | 1998-08-13 |
CN1145029A (zh) | 1997-03-12 |
CN1098686C (zh) | 2003-01-15 |
CA2187081A1 (en) | 1995-10-12 |
HUT74732A (en) | 1997-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4045070B2 (ja) | キノリン誘導体 | |
KR100571534B1 (ko) | 퀴놀린 유도체 | |
KR100551611B1 (ko) | 퀴놀린 유도체 | |
US6077851A (en) | Quinoline derivatives | |
JP2988711B2 (ja) | 縮合プリン誘導体 | |
US4833146A (en) | Tertiary hydroxyalkylxanthines, medicaments containing them and their use | |
US5965555A (en) | Xanthine compounds having terminally animated alkynol side chains | |
JPH0692407B2 (ja) | N▲上6▼−ジ置換プリン誘導体、その製法及び該誘導体を含有するアレルギ−性疾患の治療剤 | |
EP0607607B1 (de) | Xanthin Derivate | |
HU180219B (en) | Process for producing substituted xantine derivatives and salts | |
US20050272929A1 (en) | Crystalline polymorphs of (3S)-N-hydroxy-4-({4-[(4-hydroxy-2-butynul)oxy]phenyl}sulfonyl)-2,2-dimethyl-3-thiomorpholine carboxamide | |
EP0369744A2 (de) | Xanthinderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate | |
JPH09510983A (ja) | 好酸球の顆粒球の病理学的な過剰反応性を減少するためのキサンチン誘導体の使用、新規なキサンチン化合物およびそれらの製法 | |
JP3436547B2 (ja) | 頭蓋脳外傷後の二次的神経細胞損傷および機能疾患を治療するためのキサンチン誘導体の使用 | |
EP0260127A2 (de) | Xanthinderivate, ihre Herstellung und sie enthaltende pharmazeutische Präparate | |
US20020010333A1 (en) | Use of xanthine derivatives for reducing the pathological hyperreactivity of eosinophilic granulocytes, novel xanthine compounds and process for their preparation | |
HU225040B1 (en) | Novel xanthine derivatives, process for producing them and pharmaceutical compositions containing them | |
US4716160A (en) | Certain 7-amino-pyrazolo[4,3-b]pyridines useful in treating inflammatory and allergic disorders | |
CA1286665C (en) | Pyrido [1,2-a] pyrimidine derivatives | |
JPH0524889B2 (de) | ||
JPH04279586A (ja) | キサンチン誘導体 | |
KR20010043066A (ko) | 퀴놀린 유도체 | |
JPH03218378A (ja) | キサンチン誘導体 | |
MXPA00009954A (en) | Quinoline derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060822 |
|
A72 | Notification of change in name of applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A721 Effective date: 20061122 |
|
A762 | Written abandonment of application |
Free format text: JAPANESE INTERMEDIATE CODE: A762 Effective date: 20061122 |